Logo

Seegene: Richard Creager

Mar 02, 2022

Seegene has appointed Richard Creager as CEO of its US subsidiary, Seegene Technologies. Creager was chief science officer and executive officer for Beckman Coulter for nearly five years, and prior to that he was group vice president for the immunoassay & molecular diagnostics business group at Beckman. He has also served as a partner at business advisory firm IOI Partners, and was a cofounder and partner at consulting firm NaviDx. He holds a PhD in microbiology from the University of Pittsburgh School of Medicine.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.